The risk for future incident mild cognitive impairment or dementia in older women was elevated with higher levels of plasma phosphorylated tau 217, according to data published in JAMA Network Open.“Ou ...

Psychological well-being diminished before mild cognitive impairment was diagnosed. Two components had faster downturns: purpose in life and personal growth. After diagnosis of mild cognitive ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for cognition or function in patients with early Alzheimer’s.

A recent study published in the journal GeroScience suggests that a person’s overall physical and mental reserve can predict their risk of experiencing memory and thinking problems later in life.

Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...

Sleep disorders are believed to be common in people with mild cognitive impairment, with some estimates suggesting a rate as high as 60 percent. But even if you don’t have a sleep disorder that can be ...

MADRID — Primary care is the ideal setting to screen for mild cognitive impairment. Screening can be performed in under 10 minutes using brief cognitive assessment tools. When it comes to treatment, ...

Mayo Clinic researchers say people with chronic obstructive pulmonary disease (COPD) are about twice as likely as people without it to develop mild cognitive disorder (a precursor to Alzheimer's ...

A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published ...

Wednesday, Sage Therapeutics Inc (NASDAQ:SAGE) announced topline results from the PRECEDENT Phase 2 study of dalzanemdor (SAGE-718) in people with mild cognitive impairment in Parkinson’s Disease. The ...